← Browse by Condition
Medical Condition

atopic dermatitis

Total Trials
16
Recruiting Now
16
Trial Phases
Phase 4, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for atopic dermatitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — atopic dermatitis Clinical Trials

How many clinical trials are currently recruiting for atopic dermatitis?
ClinicalMetric currently tracks 16 actively recruiting clinical trials for atopic dermatitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 16. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for atopic dermatitis?
atopic dermatitis research spans Phase 2 (4 trials), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a atopic dermatitis clinical trial?
Eligibility criteria for atopic dermatitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
4
Phase 3
1
Phase 4
2
Top Sponsors
Pfizer 3 trials
National Institute of Allergy and Infectious Diseases (NIAID) 2 trials
University of California, San Diego 1 trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1 trial
Nora Mohamed Abdelrazik 1 trial

Recruiting Clinical Trials

NCT05938478
Recruiting
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
Enrollment
900 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT06004986 Phase 4
Recruiting
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
Enrollment
216 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
View Trial →
NCT07297602 Phase 2
Recruiting
Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study
Enrollment
36 pts
Location
Egypt
Sponsor
Nora Mohamed Abdelrazik
View Trial →
NCT07445919 Phase 2
Recruiting
A Clinical Study to Evaluate SM17 for Atopic Dermatitis
Enrollment
200 pts
Location
China
Sponsor
SinoMab BioScience Ltd
View Trial →
NCT05026554
Recruiting
Characterization of Chronic Hand Eczema
Enrollment
270 pts
Location
Canada
Sponsor
Dr. Robert Bissonnette
View Trial →
NCT07216027 Phase 2
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Enrollment
165 pts
Location
United States, Canad...
Sponsor
Pfizer
View Trial →
NCT06989216
Recruiting
Multi-modal Quantitative Imaging of the Skin
Enrollment
8,000 pts
Location
Sweden
Sponsor
HJN Sverige AB/Neko Health
View Trial →
NCT05099315
Recruiting
Microbiome in Atopic Dermatitis Under Systemic Therapy
Enrollment
600 pts
Location
Germany
Sponsor
Charite University, Berlin, Ge...
View Trial →
NCT06627335
Recruiting
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
Enrollment
5,621 pts
Location
United States
Sponsor
Incyte Corporation
View Trial →
NCT05721937
Recruiting
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Enrollment
400 pts
Location
United States
Sponsor
Pfizer
View Trial →
NCT04864886
Recruiting
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Enrollment
300 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →
NCT07765888 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Enrollment
375 pts
Location
United States
Sponsor
Pfizer
View Trial →
NCT07447063 Phase 4
Recruiting
The Impact of Dietary Salt on the Severity of Eczema
Enrollment
40 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT06954272
Recruiting
Characterisation of Skin Microstructure Under Normal and Atrophied States
Enrollment
180 pts
Location
United Kingdom
Sponsor
Sheffield Teaching Hospitals N...
View Trial →
NCT02504853
Recruiting
Natural History and Genetics of Food Allergy and Related Conditions
Enrollment
1,800 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →
NCT06855745 Phase 2
Recruiting
Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Enrollment
72 pts
Location
Australia
Sponsor
Alphyn Biologics
View Trial →

Related Conditions

eczema (3) atopic dermatitis eczema (3) eczema atopic (2) psoriasis (2) chronic hand eczema (1) skin cancer (1) skin diseases (1) raynaud disease (1) diabetic foot (1) peripheral arterial disease (1) pregnancy related (1) primary immunodeficiency (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology